| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.094 | 0.6 |